Susan Hamet is an accomplished professional in the pharmaceutical industry with over 30 years of experience.  Mrs. Hamet is responsible for leading DAVA’s regulatory strategy in support of the company’s aggressive plans for growth.  Prior to joining DAVA in May 2007, Mrs. Hamet spent six years with Lachman Consultant Services as a Regulatory Consultant where she guided a wide range of clientele through FDA and DEA regulatory and compliance issues of varying magnitude.  Over her extensive career, Mrs. Hamet has held numerous progressively responsible Regulatory, Quality and Compliance management positions with companies such as Ivax Pharmaceuticals (now TEVA), and Knoll Pharmaceuticals (now Abbott Laboratories).